Home » Stocks » LeMaitre Vascular

LeMaitre Vascular, Inc. (LMAT)

Stock Price: $29.97 USD 0.31 (1.05%)
Updated Aug 10, 2020 3:12 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 604.85M
Revenue (ttm) 114.67M
Net Income (ttm) 16.47M
Shares Out 20.18M
EPS (ttm) 0.81
PE Ratio 37.00
Forward PE 53.19
Dividend $0.38
Dividend Yield 1.27%

Stock Quote

Trading Day Aug 10, 2020
Last Price $29.97
Previous Close $29.66
Change ($) 0.31
Change (%) 1.05%
Day's Open 29.68
Day's Range 29.66 - 30.20
Day's Volume 31,876
52-Week Range 18.76 - 38.64

More Stats

Market Cap 604.85M
Enterprise Value 661.10M
Earnings Date (est) Oct 21, 2020
Ex-Dividend Date May 19, 2020
Shares Outstanding 20.18M
Float 16.94M
EPS (basic) 0.82
EPS (diluted) 0.81
FCF / Share 0.66
Dividend $0.38
Dividend Yield 1.27%
Earnings Yield 2.70%
FCF Yield 2.20%
Payout Ratio 43.90%
Shares Short 1.94M
Short Ratio 15.05
Short % of Float 14.09%
Beta 1.37
PE Ratio 37.00
Forward PE 53.19
P/FCF Ratio 45.42
PS Ratio 5.27
PB Ratio 3.86
Revenue 114.67M
Operating Income 20.06M
Net Income 16.47M
Free Cash Flow 13.32M
Net Cash -56.25M
Net Cash / Share -2.79
Gross Margin 69.64%
Operating Margin 17.49%
Profit Margin 14.40%
FCF Margin 11.61%
ROA 5.99%
ROE 11.35%
ROIC 17.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (6)

Buy 3
Overweight 0
Hold 3
Underweight 0
Sell 0

Analyst Consensus: Overweight

Price Target

$34.50*
(15.12% upside)
Low
30.0
Current: $29.97
High
41.0
Target: 34.50
*Average 12-month price target from 6 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue11710610189.1578.3571.1064.5556.7457.6956.06
Revenue Growth11.05%4.66%13.14%13.78%10.2%10.14%13.77%-1.65%2.9%-
Gross Profit79.8573.9470.7062.9454.1748.4345.1240.8740.2341.72
Operating Income21.1828.2121.1016.3411.156.344.523.992.964.02
Net Income17.9322.9417.1810.597.763.923.202.572.146.01
Shares Outstanding19.8119.4318.9618.4917.7616.6115.3215.1915.4615.63
Earnings Per Share0.881.130.860.550.420.230.200.160.130.37
EPS Growth-22.12%31.4%56.36%30.95%82.61%15%25%23.08%-64.86%-
Dividend Per Share0.340.280.220.180.160.140.120.100.08-
Dividend Growth21.43%27.27%22.22%12.5%14.29%16.67%20%25%--
Operating Cash Flow14.1819.5122.8716.9011.445.515.394.723.177.05
Capital Expenditures-3.76-3.05-6.42-2.84-2.28-1.19-2.90-1.33-2.09-2.56
Free Cash Flow10.4216.4516.4514.059.164.322.493.401.094.49
Cash & Equivalents32.6847.9941.6624.2927.4518.6914.7116.4520.1322.61
Total Debt15.71---------
Net Cash / Debt16.9747.9941.6624.2927.4518.6914.7116.4520.1322.61
Assets18815312610290.7081.4970.4963.0659.6963.27
Liabilities40.2022.8516.5514.4212.8213.2913.9310.177.6010.92
Book Value14813011087.5077.8868.2156.5652.8952.0952.36
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name LeMaitre Vascular, Inc.
Country United States
Employees 454
CEO George W. LeMaitre

Stock Information

Ticker Symbol LMAT
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NASDAQ: LMAT
IPO Date October 19, 2006

Description

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. The company offers angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to temporarily perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. It also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; powered phlebectomy devices to remove varicose veins; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, the company offers remote endarterectomy devices to remove plaque from arteries in the leg; valvulotomes, which cut valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, it provides vascular patches, which are used for closure of vessels after surgical intervention, as well as endarterectomy and other vascular reconstruction; vessel closure systems to attach vessels to one another with titanium clips instead of sutures; and surgical glue. The company markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.